Pro-Dex, Inc. (PDEX)
62.49
+0.28
(+0.45%)
USD |
NASDAQ |
Oct 09, 16:00
62.18
-0.31
(-0.50%)
After-Hours: 20:00
Pro-Dex Cash from Investing (Quarterly) : 0.198M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.198M |
| March 31, 2026 | -5.055M |
| December 31, 2025 | 8.868M |
| September 30, 2025 | -0.098M |
| June 30, 2025 | -0.992M |
| March 31, 2025 | 1.727M |
| December 31, 2024 | -0.542M |
| September 30, 2024 | -0.431M |
| June 30, 2024 | -0.107M |
| March 31, 2024 | -0.117M |
| December 31, 2023 | -1.883M |
| September 30, 2023 | -0.126M |
| June 30, 2023 | -0.152M |
| March 31, 2023 | -0.135M |
| December 31, 2022 | -0.508M |
| September 30, 2022 | -0.09M |
| June 30, 2022 | 0.401M |
| March 31, 2022 | -0.206M |
| December 31, 2021 | -0.556M |
| September 30, 2021 | -0.874M |
| June 30, 2021 | 0.665M |
| March 31, 2021 | 2.328M |
| December 31, 2020 | -6.728M |
| September 30, 2020 | 0.025M |
| June 30, 2020 | -0.034M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.642M |
| December 31, 2019 | -0.288M |
| September 30, 2019 | -1.323M |
| June 30, 2019 | -0.69M |
| March 31, 2019 | -0.525M |
| December 31, 2018 | 1.286M |
| September 30, 2018 | -1.293M |
| June 30, 2018 | -1.008M |
| March 31, 2018 | -0.633M |
| December 31, 2017 | -0.892M |
| September 30, 2017 | -1.582M |
| June 30, 2017 | -0.843M |
| March 31, 2017 | 0.51M |
| December 31, 2016 | -0.367M |
| September 30, 2016 | -0.326M |
| June 30, 2016 | -0.206M |
| March 31, 2016 | 1.611M |
| December 31, 2015 | 0.241M |
| September 30, 2015 | -0.058M |
| June 30, 2015 | -0.433M |
| March 31, 2015 | 0.297M |
| December 31, 2014 | -1.28M |
| September 30, 2014 | -0.097M |
| June 30, 2014 | -0.264M |
| March 31, 2014 | 0.065M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Becton, Dickinson & Co. | -228.00M |
| Abbott Laboratories | -673.00M |
| AngioDynamics, Inc. | -3.148M |
| Alphatec Holdings, Inc. | -22.72M |
| AtriCure, Inc. | -3.766M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.273M |
| Cash from Financing (Quarterly) | -1.726M |
| Free Cash Flow | 6.759M |
| Free Cash Flow Per Share (Quarterly) | -0.1445 |
| Free Cash Flow to Equity (Quarterly) | 0.754M |
| Free Cash Flow to Firm (Quarterly) | -0.2572M |
| Free Cash Flow Yield | 3.28% |